A case of primary cutaneous apocrine carcinoma treated with Tamoxifen

Q: What does this research mean for the field?

Tamoxifen treatment leads to the reduction of lymph node metastases in a patient with primary cutaneous apocrine carcinoma. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

Mio DAIDOJI; Shinpei Miura; Hirofumi Kamada; Tsuyoshi Inoue; Ayano Watanabe; H. Amano

doi:10.5227/skincancer.40.179

January 1, 2025Skin CancerOpen Access

A case of primary cutaneous apocrine carcinoma treated with Tamoxifen

View Full Paper

Ask AI

Bookmark

Share

Key Points

The aim is to evaluate the effectiveness of tamoxifen in treating primary cutaneous apocrine carcinoma.
Clinical examination revealed a 45 mm subcutaneous tumor in the chest.
Histopathological analysis confirmed the diagnosis of apocrine carcinoma.
Complete excision of the primary tumor was performed, along with lymph node biopsy.
Hormone receptor staining showed ER positive and PgR positive status.
Postoperative tamoxifen was administered based on the receptor status.
Lymph node metastasis was confirmed following surgery.
After 30 months, lymph nodes showed shrinkage without further enlargement or metastasis.

Implication

A case demonstrates positive outcomes after tamoxifen treatment in a male with apocrine carcinoma.

Abstract

No abstract yet. The journal hasn't published one we can show.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

DAIDOJI et al. (2025) studied this question.

synapsesocial.com/papers/69a287350a974eb0d3c02b2b https://doi.org/10.5227/skincancer.40.179

View Full Paper

Ask AI

Bookmark

Share

A case of primary cutaneous apocrine carcinoma treated with Tamoxifen

Key Points

Implication

Abstract

Discussion

Cite This Study

A case of primary cutaneous apocrine carcinoma treated with Tamoxifen

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading